Two Sigma Securities’s 10x Genomics TXG Stock Holding History

Two Sigma Securities’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,431	Closed	-$157K	–	2027
2025 Q3	$157K	Buy	+13,431	New	+$175K	0.02%	853
2024 Q1	–	Sell	-3,594	Closed	-$201K	–	3670
2023 Q4	$201K	Buy	+3,594	New	+$156K	﹤0.01%	2403
2022 Q4	–	Sell	-9,948	Closed	-$283K	–	3277
2022 Q3	$283K	Buy	+9,948	New	+$379K	0.01%	1635
2022 Q1	–	Sell	-3,162	Closed	-$277K	–	2522
2021 Q4	$471K	Buy	+3,162	New	+$484K	0.02%	557
2021 Q3	–	Sell	-1,337	Closed	-$262K	–	1965
2021 Q2	$262K	Buy	+1,337	New	+$242K	0.01%	1092
2020 Q1	–	Sell	-3,895	Closed	-$297K	–	2327
2019 Q4	$297K	Buy	+3,895	New	+$234K	﹤0.01%	1795

Other funds holding TXG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's TXG Position: Q4 2025 in Review

Two Sigma Securities sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 13,431 shares — an estimated $157K sold.

Two Sigma Securities first reported a position in TXG in Q4 2019 and held it in 6 quarters. The position peaked at $471K in Q4 2021. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

Two Sigma Securities reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
Two Sigma Securities sold 13,431 10x Genomics shares in Q4 2025, an estimated $157K.
Two Sigma Securities first reported a position in 10x Genomics in Q4 2019 and held it in 6 quarters.
Two Sigma Securities's 10x Genomics position peaked at $471K in Q4 2021.
322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.